ArticleContact dermatitis2022
Caution against injudicious vaccine allergy skin tests: Adverse reactions after intradermal COVID-19 vaccine testing.
Article in Contact dermatitis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 8 citations in OpenAlex.
- Intradermal skin test with mRNA vaccines as a surrogate marker of T cell immunity in immunocompromised patients.The Journal of infection · 2023Article
- Late Hypersensitivity Reactions to the BNT162b2 SARS-CoV-2 Vaccine Are Linked to Delayed Skin Sensitization and Prior Exposure to Hyaluronic Acid.Life (Basel, Switzerland) · 2022Article
- Second-dose COVID-19 vaccines are well tolerated in patients with allergic reactions to the first dose - a single center experience.The World Allergy Organization journal · 2022Article
- Caution against injudicious vaccine allergy skin tests: Adverse reactions after intradermal COVID-19 vaccine testing.Contact dermatitis · 2022Article
- Comment on "Caution against injudicious vaccine allergy skin test and adverse reactions after intradermal COVID-19 vaccine testing".Contact dermatitis · 2022Article
- Updated consensus statements on COVID-19 Vaccine Allergy Safety in Hong Kong.Asia Pacific allergy · 2022Review
Corrections and comments
- Commented on by
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.